Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | GBA1 | P04062 | 1/20 | 0.35 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.32 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.32 |
| ▸ | MANBA | O00462 | 1/20 | 0.32 |
| ▸ | IDUA | P35475 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | GUSB | P08236 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2931003 | 1.00 | LMNA (0.35) | LMNAGBA1DNMT1CTDSP1MANBA | |
| SCHEMBL813413 | 1.00 | LMNA (0.35) | LMNAGBA1DNMT1CTDSP1MANBA | |
| SCHEMBL2466059 | 1.00 | LMNA (0.35) | LMNAGBA1DNMT1CTDSP1MANBA | |
| SCHEMBL21698544 | 1.00 | LMNA (0.35) | LMNAGBA1DNMT1CTDSP1MANBA | |
| SCHEMBL4444890 | 1.00 | LMNA (0.35) | LMNAGBA1DNMT1CTDSP1MANBA | |
| SCHEMBL2466054 | 1.00 | LMNA (0.35) | LMNAGBA1DNMT1CTDSP1MANBA | |
| SCHEMBL15858 | 0.95 | LMNA (0.40) | LMNAGBA1DNMT1CTDSP1MANBA | |
| SCHEMBL6669482 | 0.95 | LMNA (0.40) | LMNAGBA1DNMT1CTDSP1MANBA | |
| SCHEMBL592850 | 0.95 | LMNA (0.40) | LMNAGBA1DNMT1CTDSP1MANBA | |
| SCHEMBL15630 | 0.95 | LMNA (0.40) | LMNAGBA1DNMT1CTDSP1MANBA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1031 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3869192-B1 | METHOD FOR QUANTITATIVE DETECTION OF VARIOUS METABOLITES IN BIOLOGICAL SAMPLE | HUMAN METABOLOMICS INST INC (CN) | 2026-05-13 | — | — | EP | claimed |
| EP-4673109-A1 | ANTIPERSPIRANT PERSONAL CARE COMPOSITIONS | Colgate-Palmolive Company (US) | 2026-01-07 | — | — | EP | claimed |
| WO-2025263641-A1 | COMPOSITION COMPRISING GLYCOLIPID, CATIONIC POLYMER AND (POLY)HYDROXY ACID | L'OREAL (FR) | 2025-12-26 | — | — | WO | claimed |
| EP-4608352-A1 | AQUEOUS MAKE-UP-REMOVING COMPOSITION HAVING A MILD PEELING EFFECT | L'OREAL (FR) | 2025-09-03 | — | — | EP | claimed |
| US-20250258146-A1 | QUANTITATIVE DETECTION METHOD OF MULTIPLE METABOLITES IN BIOLOGICAL SAMPLE AND METABOLIC CHIP | HUMAN METABOLOMICS INSTITUTE INC. (CN) | 2025-08-14 | — | — | US | claimed |
| CN-120161200-A | Alzheimer's disease biomarker based on intestinal flora metabolites and application thereof | 中国科学院深圳先进技术研究院 | 2025-06-17 | — | — | CN | claimed |
| CN-111308001-B | Metabolic marker for human macular neovascular diseases and application thereof | 上海市第一人民医院 | 2024-11-29 | — | — | CN | claimed |
| CN-118937554-A | Method for detecting residual quantity of polycyclic aromatic hydrocarbon in traditional Chinese medicinal materials | 天士力医药集团股份有限公司 | 2024-11-12 | — | — | CN | claimed |
| WO-2024206760-A1 | ANTIPERSPIRANT PERSONAL CARE COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2024-10-03 | — | — | WO | claimed |
| US-20240325272-A1 | PERSONAL CARE COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2024-10-03 | — | — | US | claimed |
| EP-0413528-B1 | Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use | YU RUEY J (US) | 1995-11-15 | — | — | EP | claimed |
| EP-0273202-B1 | Use of hydroxycarboxylic acids to enhance therapeutic effects of topical compositions for fungal infections and pigmented spots. | SCOTT EUGENE J VAN (US) | 1995-06-21 | — | — | EP | claimed |
| EP-0599819-A2 | Additives enhancing topical actions of therapeutic agents | Van Scott, Eugene J., Dr. (US) | 1994-06-01 | — | — | EP | claimed |
| WO-1992018116-A1 | COMPOSITIONS COMPRISING 2-HYDROXYCARBOXYLIC ACIDS AND RELATED COMPOUNDS, AND METHODS FOR ALLEVIATING SIGNS OF DERMATOLOGICAL AGING | YU RUEY J (US) | 1992-10-29 | — | — | WO | claimed |
| EP-0508324-A2 | Compositions comprising 2-hydroxycarboxylic acids and related compounds, and methods for alleviating signs of dermatological aging | Yu, Ruey J., Dr. (US) | 1992-10-14 | — | — | EP | claimed |
| US-5091171-A | Skin disorders | IGI, INC. | 1992-02-25 | — | — | US | claimed |
| EP-0413528-A1 | Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use | Yu, Ruey J., Dr. (US) | 1991-02-20 | — | — | EP | claimed |
| EP-0273202-A2 | Use of hydroxycarboxylic acids to enhance therapeutic effects of topical compositions for fungal infections and pigmented spots. | Van Scott, Eugene J., Dr. (US) | 1988-07-06 | — | — | EP | claimed |
| EP-0012298-B1 | PROCESS FOR THE PREPARATION OF PURE POTASSIUM RIBONATE AND PURE RIBONOLACTONE | BASF Aktiengesellschaft (DE) | 1982-05-19 | — | — | EP | claimed |
| US-4294766-A | Preparation of pure potassium ribonate and ribonolactone | BASF AKTIENGESELLSCHAFT (DE) | 1981-10-13 | — | — | US | claimed |